Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-10-05, Stock:JNJ, The news for the past five days is as follows:
2018-09-28: NEWS1: Johnson & Johnson (JNJ) Stock Moves -0.04%: What You Should Know.NEWS2: Johnson & Johnson (JNJ) Stock Moves -0.04%: What You Should Know.NEWS3: Johnson & Johnson (JNJ) Stock Moves -0.04%: What You Should Know.NEWS4: Close Update: Wall Street Caps Strong Third Quarter as Friday Fizzles.NEWS5: Close Update: Wall Street Caps Strong Third Quarter as Friday Fizzles.NEWS6: Why Geron Corporation's Stock Is Sinking, Again.NEWS7: Why Geron Corporation's Stock Is Sinking, Again.NEWS8: Mid-Day Update: Stocks Reverse Early Losses as Technical Support Holds, Italy Fades Into Bankground.NEWS9: Mid-Day Update: Stocks Reverse Early Losses as Technical Support Holds, Italy Fades Into Bankground.NEWS10: Johnson and Johnson May Rise 7% Amid Strong Growth.NEWS11: Women Health a Prime Concern Worldwide: 3 Stocks in Focus.NEWS12: Women Health a Prime Concern Worldwide: 3 Stocks in Focus.NEWS13: Why Geron Corporation&apos;s Stock Is Sinking, Again.NEWS14: Geron's Stock Plunges as J&J Ends Imetelstat Collaboration.NEWS15: Geron's Stock Plunges as J&J Ends Imetelstat Collaboration.NEWS16: Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?.NEWS17: Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?.NEWS18: EW Traded at Its 52-Week High on September 28.NEWS19: After Its Disastrous Day, What's Next for Geron Corp.?.NEWS20: After Its Disastrous Day, What's Next for Geron Corp.?.NEWS21: Geron&apos;s Stock Plunges as J&J Ends Imetelstat Collaboration.NEWS22: Wall Street Falls in Sympathy With Europe As Italian Budget Crisis Spooks Investors.NEWS23: Wall Street Falls in Sympathy With Europe As Italian Budget Crisis Spooks Investors.NEWS24: Can Geron Corporation Recover From Its Breakup With Johnson & Johnson?.NEWS25: After Its Disastrous Day, What&apos;s Next for Geron Corp.?.NEWS26: Comparing Pfizer Stock and Johnson & Johnson Stock.NEWS27: Technical Indicators for Pfizer Stock’s Movements.NEWS28: Better Buy: Geron Corporation vs. Incyte Corporation.NEWS29: Better Buy: Geron Corporation vs. Incyte Corporation.NEWS30: Better Buy: Geron Corporation vs. Incyte Corporation.NEWS31: [$$] China’s Genscript jumps after denying faking allegations.
2018-10-01: NEWS1: Healthcare ETF (IYH) Hits New 52-Week High.NEWS2: Healthcare ETF (IYH) Hits New 52-Week High.NEWS3: iShares Edge MSCI USA Quality Factor ETF Experiences Big Inflow.NEWS4: iShares Edge MSCI USA Quality Factor ETF Experiences Big Inflow.NEWS5: Healthcare ETF (IYH) Hits New 52-Week High.NEWS6: Comparing Pfizer Stock and Eli Lilly Stock.NEWS7: Where will the next big idea in healthcare come from? Johnson & Johnson is counting on nurses..
2018-10-02: NEWS1: Health Care Sector Update for 10/02/2018: VSTM,MMSI,JNJ,ICPT.NEWS2: Health Care Sector Update for 10/02/2018: VSTM,MMSI,JNJ,ICPT.NEWS3: Health Care Sector Update for 10/02/2018: MMSI,JNJ,LLY.NEWS4: Health Care Sector Update for 10/02/2018: MMSI,JNJ,LLY.NEWS5: Tracking the traders' most memorable calls in Q3.NEWS6: [$$] Johnson & Johnson Closes Sale of LifeScan to Platinum Equity.NEWS7: Are You Looking for a High-Growth Dividend Stock? Johnson & Johnson (JNJ) Could Be a Great Choice.NEWS8: Are You Looking for a High-Growth Dividend Stock? Johnson & Johnson (JNJ) Could Be a Great Choice.NEWS9: Are You Looking for a High-Growth Dividend Stock? Johnson & Johnson (JNJ) Could Be a Great Choice.NEWS10: Health Care Sector Update for 10/02/2018: JNJ,LLY.NEWS11: Health Care Sector Update for 10/02/2018: JNJ,LLY.NEWS12: A Look at GlaxoSmithKline’s Consumer Healthcare Business.NEWS13: Platinum Equity Completes $2.1 Billion Acquisition of LifeScan From Johnson & Johnson.NEWS14: Johnson & Johnson Completes Divestiture of LifeScan to Platinum Equity.NEWS15: Johnson & Johnson Closes Sale Of LifeScan Business To Platinum Equity.NEWS16: Johnson & Johnson Closes Sale Of LifeScan Business To Platinum Equity.
2018-10-03: NEWS1: Merck CEO sees a disintermediation in pharma like the cable industry.NEWS2: Platinum Equity completes $2B purchase of J&J’s LifeScan.NEWS3: Mergers and Acquisitions in the Pharmaceuticals Sector in Q3 2018.NEWS4: Here's Why J&J (JNJ) is a Good Bet in a Troubled Market.NEWS5: Here's Why J&J (JNJ) is a Good Bet in a Troubled Market.NEWS6: Novartis, Boston Pharma Ink Deal for 3 Anti-Infective Drugs.NEWS7: Novartis, Boston Pharma Ink Deal for 3 Anti-Infective Drugs.NEWS8: Merck & Other Pharma Players Await FDA Decisions in October.NEWS9: Merck & Other Pharma Players Await FDA Decisions in October.NEWS10: Here&apos;s Why J&J (JNJ) is a Good Bet in a Troubled Market.NEWS11: MARKETS: Dow hits another record with Intel, Apple, Caterpillar leading—even small caps are on board.NEWS12: A Look at Elanco, Eli Lilly’s Animal Health Business.NEWS13: Novartis, Boston Pharma Ink Deal for 3 Anti-Infective Drugs.NEWS14: Merck & Other Pharma Players Await FDA Decisions in October.NEWS15: Health Care Sector Update for 10/03/2018: JNJ, PFE, AMGN, MRK, ABT, ELGX, NVCN, KALA.NEWS16: Health Care Sector Update for 10/03/2018: JNJ, PFE, AMGN, MRK, ABT, ELGX, NVCN, KALA.NEWS17: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 04, 2018.NEWS18: Bristol-Myers Squibb Company (BMY) Ex-Dividend Date Scheduled for October 04, 2018.NEWS19: Dow Jones Futures Rise On Italy: Upwork IPO Set To Debut; News On Nike, Microsoft, J&J.NEWS20: Will This IRS Spinoff Rule Help Pharma and Big Tech?.NEWS21: Will This IRS Spinoff Rule Help Pharma and Big Tech?.NEWS22: Will This IRS Spinoff Rule Help Pharma and Big Tech?.
2018-10-04: NEWS1: MARKETS: Don't freak out about today's selloff, but retail is still in trouble.NEWS2: Top Performing ETFs of the Third Quarter.NEWS3: Top Performing ETFs of the Third Quarter.NEWS4: J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion.NEWS5: 7 Healthcare Stocks to Buy Right Now.NEWS6: Seattle Genetics: Impact of the Cascadian Acquisition.NEWS7: Stocks - Apple, Amazon Fall in Pre-market; Barnes & Noble Surges.NEWS8: J&J's Phase III Data Shows Switch to its HIV Drug Beneficial.NEWS9: J&J's Phase III Data Shows Switch to its HIV Drug Beneficial.NEWS10: Health-Care Stocks’ High Valuations May Not Be a Problem.NEWS11: Arrowhead Announces $3.7B License Agreement With Janssen For Gene-Silencing Drug.NEWS12: J&J&apos;s Phase III Data Shows Switch to its HIV Drug Beneficial.NEWS13: J&J, Arrowhead in gene-silencing drug deal worth up to $3.7 billion.NEWS14: The Daily Biotech Pulse: AtriCure's Guidance, Guardant Health And Kodiak To Debut.NEWS15: UPDATE: Arrowhead Pharma stock surges 19% on news of $3.7 billion license agreement with Janssen.NEWS16: Eli Lilly’s Stock Performance and Estimates for Q3 2018.NEWS17: Arrowhead Enters $3.7 Bln License And Collaboration Deals With Janssen.NEWS18: Arrowhead Enters $3.7 Bln License And Collaboration Deals With Janssen.NEWS19: Moody's: Biosimilars a growing challenge biotech drugs, with European market developing more quickly than the US.

Answer: Decrease